GraBis Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $848.55

  • Investors
  • 3

GraBis General Information

Description

Developer of diagnostic technologies designed to detect disease-specific biomarkers with high precision. The company's platform offers magnetic nanoparticle-based detection and targeted biomarker analysis capabilities, enabling clinicians and diagnostic laboratories to accurately and efficiently identify critical health conditions across multiple fatal disease groups.

Contact Information

Website
grabis.co.kr
Formerly Known As
KingoBio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 811, 306, Digital-ro
  • Guro-gu
  • Seoul
  • South Korea
+82
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Corporate Office
  • Room 811, 306, Digital-ro
  • Guro-gu
  • Seoul
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GraBis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 19-May-2025 $848.55 Completed Generating Revenue
2. Grant Completed Startup
1. Seed Round 01-Jan-2021 $183K $183K Completed Startup
To view GraBis’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

GraBis Patents

GraBis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230393128-A1 Polymeric material-coated nanoparticle complex for isolation of biological target and preparation method therefor Pending 17-Feb-2021
WO-2022177326-A1 Polymeric material-coated nanoparticle complex for isolation of biological target and preparation method therefor Inactive 17-Feb-2021

GraBis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GraBis Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Busan United Holdings Accelerator/Incubator Minority
Sazze Partners Venture Capital Minority
Korea University Holdings Accelerator/Incubator Minority
To view GraBis’s complete investors history, request access »

GraBis FAQs

  • When was GraBis founded?

    GraBis was founded in 2018.

  • Where is GraBis headquartered?

    GraBis is headquartered in Seoul, South Korea.

  • What is the size of GraBis?

    GraBis has 8 total employees.

  • What industry is GraBis in?

    GraBis’s primary industry is Diagnostic Equipment.

  • Is GraBis a private or public company?

    GraBis is a Private company.

  • What is GraBis’s current revenue?

    The current revenue for GraBis is .

  • How much funding has GraBis raised over time?

    GraBis has raised $184K.

  • Who are GraBis’s investors?

    Busan United Holdings, Sazze Partners, and Korea University Holdings have invested in GraBis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process